The Evicel Post-Authorization Surveillance Study

NCT01158261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-08-19

Study results available
· View outcomes & findings →

Summary

The objective of this non-interventional Post Authorisation Safety Surveillance (PASS) study is to observe the clinical safety performance of EVICEL when used as suture support for haemostasis in vascular surgery.

Conditions

Interventions

BIOLOGICAL

EVICEL ™ Fibrin Sealant (Human)

Commercial Evicel

Sponsors & Collaborators

  • OMRIX Biopharmaceuticals

    collaborator INDUSTRY
  • Ethicon, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard Kocharian, MD · Ethicon, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2014-04-30
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01158261 on ClinicalTrials.gov